Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [620]
News [2060]
Articles [144]
Editorials [6]
Conferences [76]
elearning [20]
Maximising diagnosis of colon cancer with target screening
Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA
Maximising diagnosis of colon cancer with target screening ( Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA )
25 May 2023
Optimising colon cancer care in Nigeria
Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA
Optimising colon cancer care in Nigeria ( Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA )
25 May 2023
Tackling low-volumes of clinical trials in Africa
Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria
Tackling low-volumes of clinical trials in Africa ( Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria )
25 May 2023
The HypoAfrica study and AC3T research partnerships at NLCC
Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria
The HypoAfrica study and AC3T research partnerships at NLCC ( Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria )
17 May 2023
Achieving health equity in cancer care in the Philippines
Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The...
Achieving health equity in cancer care in the Philippines ( Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines )
10 May 2023
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )
9 May 2023
Pembro plus gemcitabine and cisplatin potential option for metastatic or...
Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
2 May 2023
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC
Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh...
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC ( Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia )
27 Apr 2023
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023
Higher BMI may be linked with worse survival among SBS88 positive CRC patients
Dr Claire Thomas - Fred Hutchinson Cancer Center, Seattle, USA
Higher BMI may be linked with worse survival among SBS88 positive CRC patients ( Dr Claire Thomas - Fred Hutchinson Cancer Center, Seattle, USA )
20 Apr 2023
Key practices for handling difficult conversations in cancer care
Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila...
Key practices for handling difficult conversations in cancer care ( Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila, Philippines )
19 Apr 2023
Choosing wisely in complementary treatment for cancer in the Philippines
Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital...
Choosing wisely in complementary treatment for cancer in the Philippines ( Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines )
19 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation